SCHEMBL6479819

SCHEMBL6479819

Cc1c2c(nc3ccccc13)COC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
KDM4E B2RXH2 8/20 0.54
CYP1A2 P05177 6/20 0.51
MAPT P10636 4/20 0.50
MAPK1 P28482 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
HPGD P15428 5/20 0.44
POLB P06746 2/20 0.44
HTT P42858 1/20 0.44
HSD17B10 Q99714 5/20 0.43
CYP3A4 P08684 4/20 0.43
CYP2D6 P10635 3/20 0.43
CYP2C19 P33261 3/20 0.43
TSHR P16473 2/20 0.43
CASP1 P29466 1/20 0.43
BCHE P06276 2/20 0.42
ACHE P22303 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6479814 0.79 ACHE (0.42) ALDH1A1KDM4ECYP1A2MAPTMAPK1
SCHEMBL12442826 0.77 BCHE (0.65) ALDH1A1KDM4ECYP1A2MAPTMAPK1
SCHEMBL12442843 0.75 ALDH1A1 (0.73) ALDH1A1KDM4ECYP1A2MAPTMAPK1
SCHEMBL527199 0.74 ACHE (0.65) ALDH1A1KDM4ECYP1A2MAPTMAPK1
SCHEMBL11870225 0.72 MAPT (0.50) ALDH1A1KDM4ECYP1A2MAPTMAPK1
SCHEMBL527589 0.72 BCHE (0.66) ALDH1A1KDM4ECYP1A2MAPTMAPK1
SCHEMBL8390418 0.71 ALDH1A1 (0.54) ALDH1A1KDM4ECYP1A2MAPTMAPK1
SCHEMBL3288428 0.71 ALDH1A1 (0.57) ALDH1A1KDM4ECYP1A2MAPTMAPK1
SCHEMBL9693861 0.70 ALDH1A1 (0.54) ALDH1A1KDM4ECYP1A2MAPTMAPK1
SCHEMBL11832472 0.70 ALDH1A1 (0.55) ALDH1A1KDM4ECYP1A2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed